Prevalence of Nitroimidazole-Refractory Giardiasis Acquired in Different World Regions, Sweden, 2008-2020. [PDF]
Ydsten KA +3 more
europepmc +1 more source
A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial. [PDF]
Chu N +15 more
europepmc +1 more source
<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>. [PDF]
Rupasinghe P +15 more
europepmc +1 more source
Evaluación de la Degradación de Metronidazol en Solución Acuosa por Peroxidación Electroquímica con Electrodos de Fe [PDF]
Nolasco Gómez, Sandra Luz +1 more
core
Increasing Antimicrobial Resistance to First-Line Therapies in Chronic Endometritis: A 2020-2024 Cross-Sectional Study. [PDF]
Cicinelli E +10 more
europepmc +1 more source
Pneumonia with parapneumonic effusion due to <i>Fusobacterium necrophorum</i>: a case report. [PDF]
Dong X, Li Q, Zhu A, Wu X, Wu X.
europepmc +1 more source
In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles. [PDF]
Kerek Á +6 more
europepmc +1 more source
Impact of Lactobacillus johnsonii CNCM I-4884 on canine giardiasis: a probiotic-based approach. [PDF]
Polack B +8 more
europepmc +1 more source
Novel Prodrug Strategies for the Treatment of Tuberculosis. [PDF]
Kim CG, Jose J, Hay MP, Choi PJ.
europepmc +1 more source
Role of Clinical Pharmacists in Antimicrobial Therapy for Patients with Septic Shock in the ICU. [PDF]
Mai S, Wang Y, Zhu J, Yang B.
europepmc +1 more source

